AGT-181

· ArmaGen, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGT-181, covering 2023-03-15 to 2023-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I [Phase 1, Phase 2]